The text-to-speech industry is witnessing significant growth in 2025, propelled by advancements in AI-driven voice generator ...

HANOI, VIETNAM - Media OutReach Newswire - 4 April 2025 – VinFast will make its first appearance at the Manila International ...

“By invoking emergency power to impose an across-the-board tariff on imports from China that the statute does not authorize, President Trump has misused that power, usurped Congress’s right to control ...

Ms. Whitaker is an accomplished C-suite leader, most recently as Chair and CEO of Aerami Therapeutics Holdings Inc. During her executive career she has held senior leadership roles at GlaxoSmithKline ...

On April 3, 2025, AppLovin (APP) Corporation confirmed that the Company has provided an indication of interest to the President of the United States to explore a purchase of TikTok in all markets ...

DIV is a multi-royalty corporation, engaged in the business of acquiring top-line royalties from well-managed multi-location businesses and franchisors in North America. DIV’s objective is to acquire ...

Riot Platforms (RIOT) reported unaudited production and operations updates for March 2025. Riot mined 533 bitcoin in March, up 25% vs. March ...

Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, announced today that its Board of Directors (the “Board”) has ...

MIAMI, April 03, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) announced that it will report results for the second fiscal quarter ended March 31, 2025 ...

Vaidio’s winning 9th generation platform features powerful agentic intelligence and GenAI capabilities. A new camera auto-configuration agent uses the latest vision language models (VLMs) to automate ...

With 93% of team members agreeing that Credit Acceptance is a great place to work, the Company is continuously ranked as one of the best places to work. We remain committed to fostering an environment ...

Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million ...